Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective studyFumihiko Urabe, Takahiro Kimura, Shuhei Hara et al.|Prostate International|2024Cited by 6
Optimal timing for initiating androgen receptor signaling inhibitor therapy in patients with nonmetastatic castration-resistant prostate cancer: a multicenter collaborative studyShuhei Hara, Fumihiko Urabe, Kojiro Tashiro et al.|Japanese Journal of Clinical Oncology|2024Cited by 4
Novel Preoperative Immune Prognostic Index for Predicting Outcomes in Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial CarcinomaKen Shibata, Fumihiko Urabe, Kosuke Iwatani et al.|In Vivo|2025Cited by 1